• 1153 Citations
  • 20 h-Index
1992 …2018

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

  • 1153 Citations
  • 20 h-Index
  • 40 Article
  • 5 Review article
  • 3 Letter
  • 1 Comment/debate
Filter
Article
2018
2 Citations (Scopus)
2017

Clinical decision making and mental health service use among persons with severe mental illness across Europe

Cosh, S., Zenter, N., Ay, E. S., Loos, S., Slade, M., De Rosa, C., Luciano, M., Berecz, R., Glaub, T., Munk-Jørgensen, P., Bording, M. K., Rössler, W., Kawohl, W. & Puschner, B., szept. 1 2017, In : Psychiatric Services. 68, 9, p. 970-974 5 p.

Research output: Article

4 Citations (Scopus)
5 Citations (Scopus)
2016

Unanswered questions in the transcranial magnetic stimulation treatment of patients with depression

Morvai, S., Nagy, A., Kovács, A., Móré, C. E., Berecz, R. & Frecska, E., jan. 30 2016, In : Ideggyógyászati szemle. 69, 1-2, p. 4-11 8 p.

Research output: Article

2 Citations (Scopus)
2015
5 Citations (Scopus)

Neurocognitive changes in patients with schizophrenia during relapse and early remission

Balogh, N., Égerházi, A. & Berecz, R., júl. 2015, In : European Journal of Psychiatry. 29, 3, p. 199-209 11 p.

Research output: Article

1 Citation (Scopus)
2014

Investigating the state-like and trait-like characters of social cognition in schizophrenia: A short term follow-up study

Balogh, N., Égerházi, A., Berecz, R. & Csukly, G., nov. 1 2014, In : Schizophrenia Research. 159, 2-3, p. 499-505 7 p.

Research output: Article

20 Citations (Scopus)

Liver enzyme abnormalities during antipsychotic treatment: A case report of risperidone-associated hepatotoxicity

López-Torresa, E., Süvegesa, Á., Peñas-Lledó, E. M., Doña, A., Dorado, P., LLerena, A. & Berecz, R., jan. 1 2014, In : Drug metabolism and drug interactions. 29, 2, p. 123-126 4 p.

Research output: Article

3 Citations (Scopus)
2013

A CANTAB alkalmazása depresszióban - előzetes adatok

Egerhazi, A., Balla, P., Ritzl, A., Varga, Z., Frecska, E. & Berecz, R., jan. 1 2013, In : Neuropsychopharmacologia Hungarica. 15, 1, p. 5-11 7 p.

Research output: Article

9 Citations (Scopus)

Development and psychometric properties of a five-language multiperspective instrument to assess clinical decision making style in the treatment of people with severe mental illness (CDMS)

Puschner, B., Neumann, P., Jordan, H., Slade, M., Fiorillo, A., Giacco, D., Égerházi, A., Ivánka, T., Bording, M. K., Sørensen, H. Ø., Bär, A., Kawohl, W., Loos, S., Arnold, K., Ay, E., Becker, T., Konrad, J., Steffen, S., Zentner, N., Clarke, E. & 21 others, Maj, M., Luciano, M., De Rosa, C., Sampogna, G., Del Vecchio, V., Cozzolino, P., Del Vecchio, H. G., Salzano, A., Nagy, M., Berecz, R., Glaub, T., Süveges, Á., Kovacs, A., Magyar, E., Munk-Jørgensen, P., Sørensen, H. Ø., Larsen, J. I., Rössler, W., Krömer, S., Mutschler, J. & Obermann, C., febr. 4 2013, In : BMC psychiatry. 13, 48.

Research output: Article

24 Citations (Scopus)
2008

P300 enyhe kognitív zavarban és demenciában.

Egerházi, A., Glaub, T., Balla, P., Berecz, R. & Degrell, I., 2008, In : Psychiatria Hungarica : A Magyar Pszichiátriai Társaság tudományos folyóirata. 23, 5, p. 349-357 9 p.

Research output: Article

14 Citations (Scopus)
2007
118 Citations (Scopus)
2006
2 Citations (Scopus)
2005

Cognitive functions in prepsychotic patients

Bartók, E., Berecz, R., Glaub, T. & Degrell, I., máj. 2005, In : Progress in Neuro-Psychopharmacology and Biological Psychiatry. 29, 4, p. 621-625 5 p.

Research output: Article

61 Citations (Scopus)
15 Citations (Scopus)
3 Citations (Scopus)

Reduced completed suicide rate in Hungary from 1990 to 2001: Relation to suicide methods

Berecz, R., Cáceres, M., Szlivka, A., Dorado, P., Bartók, E., Peñas-Lledó, E., Llerena, A. & Degrell, I., okt. 1 2005, In : Journal of affective disorders. 88, 2, p. 235-238 4 p.

Research output: Article

13 Citations (Scopus)
2004
4 Citations (Scopus)

Effect of CYP2D6 and CYP2C9 genotypes on fluoxetine and norfluoxetine plasma concentrations during steady-state conditions

LLerena, A., Dorado, P., Berecz, R., González, A. P. & Peñas-LLedó, E. M., febr. 1 2004, In : European Journal of Clinical Pharmacology. 59, 12, p. 869-873 5 p.

Research output: Article

58 Citations (Scopus)

QTc interval, CYP2D6 and CYP2C9 genotypes and risperidone plasma concentrations

Llerena, A., Berecz, R., Dorado, P. & De La Rubis, A., jún. 1 2004, In : Journal of Psychopharmacology. 18, 2, p. 189-193 5 p.

Research output: Article

61 Citations (Scopus)

Relationship between haloperidol plasma concentration, debrisoquine metabolic ratio, CYP2D6 and CYP2C9 genotypes in psychiatric patients

Llerena, A., De La Rubia, A., Berecz, R. & Dorado, P., márc. 1 2004, In : Pharmacopsychiatry. 37, 2, p. 69-73 5 p.

Research output: Article

17 Citations (Scopus)
2003
20 Citations (Scopus)

CYP2C9 gene and susceptibility to major depressive disorder

Llerena, A., Berecz, R., Dorado, P., González, A. P., Peñas-Lledó, E. M. & De la Rubia, A., nov. 27 2003, In : Pharmacogenomics Journal. 3, 5, p. 300-302 3 p.

Research output: Article

22 Citations (Scopus)

CYP2C9 genotypes and diclofenac metabolism in Spanish healthy volunteers

Dorado, P., Berecz, R., Norberto, M. J., Yasar, Ü., Dahl, M. L. & LLerena, A., júl. 1 2003, In : European Journal of Clinical Pharmacology. 59, 3, p. 221-225 5 p.

Research output: Article

87 Citations (Scopus)
51 Citations (Scopus)
47 Citations (Scopus)

Reproducibility over time of the urinary diclofenac/4′-OH diclofenac ratio among different CYP2C9 genotypes

Dorado, P., Berecz, R., Cáceres, M. C., Conzález, I. & Llerena, A., jan. 1 2003, In : European Journal of Drug Metabolism and Pharmacokinetics. 28, 3, p. 213-215 3 p.

Research output: Article

2 Citations (Scopus)

Thioridazine steady-state plasma concentrations are influenced by tobacco smoking and CYP2D6, but not by the CYP2C9 genotype

Berecz, R., De La Rubia, A., Dorado, P., Fernández-Salguero, P., Dahl, M. L. & LLerena, A., máj. 1 2003, In : European Journal of Clinical Pharmacology. 59, 1, p. 45-50 6 p.

Research output: Article

50 Citations (Scopus)
2002

[15O]-butanol PET-vizsgálatok térbeli standardizálása szegmentált, T1-súlyozott MRI-felvételek segítségével.

Emri, M., Bogner, P., Balkay, L., Tóth, A., Kisely, M., Weisz, J., Adám, G., Glaub, T., Berecz, R. & Repa, I., máj. 26 2002, In : Orvosi hetilap. 143, 21 Suppl 3, p. 1249-1251 3 p.

Research output: Article

Auditoros eseményhez kötött potenciál és PET: lehetóség a kogníció folyamatának komplex megközelítésére.

Glaub, T., Berecz, R., Lengyel, Z., Emri, M., Márián, T., Bartók, E., Trón, L. & Degrell, I., máj. 26 2002, In : Orvosi hetilap. 143, 21 Suppl 3, p. 1322-1324 3 p.

Research output: Article

QTc interval lengthening is related to CYP2D6 hydroxylation capacity and plasma concentration of thioridazine in patients

LLerena, A., Berecz, R., De la Rubia, A. & Dorado, P., dec. 2002, In : Journal of Psychopharmacology. 16, 4, p. 361-364 4 p.

Research output: Article

59 Citations (Scopus)

Relación entre los síntomas de discontinuación y los niveles plasmáticos de clozapina

Berecz, R., De La Rubia Martínez, A., Norberto Gamero, M. J., Gutiérrez Casares, J. R., Glaub, T., Degrell, I. & Llerena, A., nov. 1 2002, In : Actas Espanolas de Psiquiatria. 30, 6, p. 397-399 3 p.

Research output: Article

Relationship between risperidone and 9-hydroxy-risperidone plasma concentrations and CYP2D6 enzyme activity in psychiatric patients

Berecz, R., LLerena, A., De la Rubia, A., Gómez, J., Kellermann, M., Dorado, P. & Degrell, I., nov. 1 2002, In : Pharmacopsychiatry. 35, 6, p. 231-234 4 p.

Research output: Article

43 Citations (Scopus)
2001
21 Citations (Scopus)

Effect of thioridazine dosage on the debrisoquine hydroxylation phenotype in psychiatric patients with different CYP2D6 genotypes

Llerena, A., Berecz, R., De la Rubia, A., Fernández-Salguero, P. & Dorado, P., dec. 5 2001, In : Therapeutic Drug Monitoring. 23, 6, p. 616-620 5 p.

Research output: Article

42 Citations (Scopus)
2000

Clozapine withdrawal symptoms after change to sertindole in a schizophrenic patient

Berecz, R., Glaub, T., Kellermann, M., De La Rubia, A., LLerena, A. & Degrell, I., jan. 1 2000, In : Pharmacopsychiatry. 33, 1, p. 42-44 3 p.

Research output: Article

6 Citations (Scopus)

Olanzapin intoxikacio

Berecz, R., Kellermann, M., Glaub, T. & Degrell, I., jan. 1 2000, In : Psychiatria Hungarica. 15, 2, p. 176-178 3 p.

Research output: Article

2 Citations (Scopus)

Use of the mesoridazine/thioridazine ratio as a marker for CYP2D6 enzyme activity

Llerena, A., Berecz, R., De la Rubia, A., Norberto, M. J. & Benitez, J., aug. 26 2000, In : Therapeutic Drug Monitoring. 22, 4, p. 397-401 5 p.

Research output: Article

36 Citations (Scopus)
1999

Pharmacokinetic interaction of fluvoxamine and thioridazine in schizophrenic patients

Carrillo, J. A., Ramos, S. I., Herraiz, A. G., Llerena, A., Agundez, J. A. G., Berecz, R., Duran, M. & Benítez, J., dec. 1 1999, In : Journal of Clinical Psychopharmacology. 19, 6, p. 494-499 6 p.

Research output: Article

54 Citations (Scopus)
1998

Antibiotic use in 3 European university hospitals

Kiivet, R. A., Dahl, M. L., Llerena, A., Maimets, M., Wettermark, B. & Berecz, R., okt. 20 1998, In : Scandinavian Journal of Infectious Diseases. 30, 3, p. 277-280 4 p.

Research output: Article

45 Citations (Scopus)